DISCOVER is a Marie Sklodowska-Curie and Horizon 2020 project bringing together researchers in the fields of cell death signalling, immunology, protein structural chemistry, drug design, bioinformatics and computational biology in a network that will exchange reagents, technologies and knowledge. This cross-sectoral network will form a synergistic environment that aims to aid in understanding how the…


TREATMENT is a Marie Sklodowska Curie Innovative Training Network proposal directly addressing the need for high-level training and career paths in risk evaluation of drug induced metabolic dysfunctions, a relevant aspect, so far unexplored by traditional toxicology studies, but urgently needed to challenge current severe limitations of health care interventions.


BRAF mutant (MT) colorectal cancer (CRC) accounts for 10-15% of CRC and represents the subgroup with the worst overall survival. There is an urgent need to identify strategies that hit the ‘Achilles Heel’ in poor prognostic BRAFMT CRC. Preliminary data from the host lab have shown that BRAFMT CRC cells are vulnerable to disturbances in…

%d bloggers like this: